Biolegend, 100320, PE/Cyanine7 anti-mouse CD3ε Antibody, 100μg

CD3ε is a 20 kD transmembrane protein, also known as CD3 or T3. It is a member of the Ig superfamily and primarily expressed on T cells, NK-T cells, and at different levels on thymocytes during T cell differentiation. CD3ε forms a TCR complex by associating with the CD3δ, γ and ζ chains, as well as the TCR α/β or γ/δ chains. CD3 plays a critical role in TCR signal transduction, T cell activation, and antigen recognition by binding the peptide/MHC antigen complex.
100μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Armenian Hamster
Immunogen: H-2Kb-specific mouse cytotoxic T lymphocyte clone BM10-37
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
Excitation Laser: Blue Laser (488 nm)Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes: Clone 145-2C11 is useful for in vitro blocking of target-specific CTL-mediated cell lysis1, as well as T cell activation assays, inducing proliferation and cytokine production1,2,7,12,16. It also induces apoptosis in immature thymocytes32, and in vivo T cell depletion8-10. Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1, immunohistochemical staining14,15 of acetone-fixed frozen sections and zinc-fixed paraffin-embedded sections, Western blotting4, complement-mediated cytotoxicity6, in vitro and in vivo stimulation of T cells1,2,7,12,16, immunofluorescent staining5, and in vivo T cell depletion8-10. The 145-2C11 antibody has been reported to block the binding of 17A2 antibody to CD3 epsilon-specific T cells11. Clone 145-2C11 is not recommended for formalin-fixed paraffin embedded sections. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 100314). For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 100340) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).
Application References(PubMed link indicates BioLegend citation): Leo O, et al. 1987. P. Natl. Acad. Sci. USA 84:1374. (IP, Activ, Block) Kruisbeek AM, et al. 1991. In Current Protocols in Immunology. 3.12.1. (Activ) Duke RC, et al. 1995. Current Protocols in Immunology. 3.17.1. Salvadori S, et al. 1994. J. Immunol. 153:5176. (WB) Payer E, et al. 1991. J. Immunol. 146:2536. (IF) Jacobs H, et al. 1994. Eur. J. Immunol. 24:934. (CMCD) Vossen ACTM, et al. 1995. Eur. J. Immunol. 25:1492. (Activ) Henrickson M, et al. 1995. Transplantation 60:828. (Deplete) Kinnaert P, et al. 1996. Transpl. Int. 9:386. (Deplete) Han WR, et al. 1999. Transpl. Immunol. 7:207. (Deplete) Miescher GC, et al. 1989. Immunol. Lett. 23:113. (Block) Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Activ) Ko SY, et al. 2005. J. Immunol. 175:3309. Podd BS, et al. 2006. J. Immunol. 176:6532. (IHC-F) Tilley SL, et al. 2007. J. Immunol. 178:3208. (IHC-F) Wang W, et al. 2007. J. Immunol. 178:4885. (Activ) Xiao S, et al. 2007. J. Exp. Med. 204:1691. Chappaz S, et al. 2007. Blood doi:10.1182/blood-2007-02-074245. (FC) PubMed. Curtsinger JM, et al.2005. J. Immunol. 175:4392. PubMed Guo Y, et al. 2008. Blood 112:480. PubMed Kenna TJ, et al. 2008. Blood 111:2091. Perchonock CE, et al. 2007. J. Immunol. 179:1768. PubMed Perchonock GE, et al. 2006. Mol. Cell. Biol. 26:6005. PubMed Kanaya T, et al. 2008. Am. J. Physiol. Gastrointest. Liver Physiol. 295:G273. PubMed de Koning BA, et al. 2006. Int. Immunol. 18:941. PubMed Schulteis RD, et al. 2008. Blood 295:G273. PubMed Qi Q, et al. 2009. Blood 114:564. PubMed Helmersson S, et al. 2013. Am J Pathol. 9440:123. Pubmed Wu S, et al. 2014. Clin Vaccine Immunol. 21:156. PubMed Yan J, et al. 2014. Vaccine. 32:2833. PubMed Guiterrez DA, et al. 2014. Diaebetes. 63:3827. PubMed Shi YF, et al. 1991. J Immunol. 146:3340. (Apop)
Product Citations: Huang Y, et al. 2015. Proc Natl Acad Sci U S A. 112:39. PubMed Cabañero D, et al. 2020. Elife. 9:00. PubMed Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed Strickley JD, et al. 2019. Nature. 575:519. PubMed Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed Deák P, et al. 2022. Cell Rep. 41:111563. PubMed Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed Wang Z, et al. 2023. J Cancer. 14:1049. PubMed Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed Meng J, et al. 2022. Cell Rep. 38:110492. PubMed Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed Zhang Y, et al. 2022. Vaccines (Basel). 10: . PubMed Dölz M, et al. 2022. iScience. 25:105372. PubMed Ye L, et al. 2022. Cell Metab. 34:595. PubMed Oetjen LK et al. 2017. Cell. 171(1):217-228 . PubMed Zhou J, et al. 2019. Immunity. 50:403. PubMed Tatsuguchi T, et al. 2022. Int Immunol. 34:277. PubMed Zhu H, et al. 2018. Elife. 7:. PubMed Buxadé M, et al. 2018. J Exp Med. 215:2901. PubMed Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed Li ZX, et al. 2022. Arch Virol. :. PubMed Huai W, et al. 2019. J Exp Med. 216:772. PubMed Tan L, et al. 2019. Cell Rep. 27:3657. PubMed Schulthess J et al. 2019. Immunity. 50(2):432-445 . PubMed Gopinathan G, et al. 2022. Mol Cancer Ther. 21:1030. PubMed Ma C, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed Tian H, et al. 2022. Cancer Sci. 113:875. PubMed Zhao B, et al. 2021. Cell Reports. 36(3):109401. PubMed Bartleson JM, et al. 2020. Nat Immunol. 1384:21. PubMed Demircioglu F, et al. 2020. Nat Commun. 11:1290. PubMed Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed Li Z, et al. 2022. Elife. 11:. PubMed Cousin N, et al. 2021. Cancer Res. 81:4133. PubMed Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed Xiao Y, et al. 2021. Cancer Cell. 39(3):423-437.e7. PubMed Emgård J, et al. 2018. Immunity. 143:419. PubMed Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed Deng Z, et al. 2017. Oncogene. 36:639. PubMed Westfall S, et al. 2020. Brain Behav Immun. . PubMed He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed Wu Y, et al. 2021. Nat Commun. 12:2346. PubMed Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed Lu M, et al. 2021. J Virol. 95:e0059221. PubMed Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed Murakami R, et al. 2013. PLoS One. 8:73270. PubMed Williams JW, et al. 2017. Circ Res. 121:662. PubMed Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed Wu S, et al. 2022. BMC Immunol. 23:17. PubMed Wang R, et al. 2022. Front Immunol. 13:947756. PubMed De Ponte Conti B, et al. 2021. Elife. 10:. PubMed Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed Li J, et al. 2013. Arch Immunol Ther Exp (Warsz). 61:237. PubMed Huang Y, et al. 2016. J Immunol. 196: 217 - 231. PubMed Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed Shiozawa S, et al. 2022. iScience. 25:103537. PubMed Chen C, et al. 2021. J Virol. 95:e0082921. PubMed Riva A, et al. 2017. PLoS One.. 10.1371/journal.pone.0181964. PubMed Yasuma K, et al. 2016. PLoS Pathog. 12: 1005372. PubMed Maniati E, et al. 2020. Cell Rep. 30:525. PubMed Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed Takahashi T, et al. 2017. J Exp Med. 10.1084/jem.20160247. PubMed Halim TYF et al. 2018. Immunity. 48(6):1195-1207 . PubMed Yoshida H, et al. 2019. Cell. 176:897. PubMed Ireland L, et al. 2020. Front Immunol. 11:297. PubMed Hong JP, et al. 2020. Cell Reports Medicine. 1(3):100035. PubMed Qi Q, et al. 2009. Blood. 114:564. PubMed Tzeng TT, et al. 2022. NPJ Vaccines. 7:60. PubMed Fitzpatrick Z, et al. 2020. Nature. 587:472. PubMed Chen J, et al. 2014. Cell Res. 24:1050. PubMed Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed White JP et al. 2018. Cell. 175(5):1198-1212 . PubMed Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed Celorrio M, et al. 2022. Acta Neuropathol Commun. 10:10. PubMed Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed Wang Y, et al. 2020. Immunity. 53(6):1168-1181.e7. PubMed Goc J, et al. 2021. Cell. 184:5015. PubMed Li Z et al. 2018. Immunity. 49(4):640-653 . PubMed Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed Nabekura T, et al. 2020. Immunity. 96:52. PubMed Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
RRID: AB_312684 (BioLegend Cat. No. 100319) AB_312685 (BioLegend Cat. No. 100320)
Structure: Ig superfamily, forms CD3/TCR complex with CD3δ, γ and ζ subunits and TCR (α/β and γ/δ), 20 kD
Distribution: Thymocytes (differentiation dependent), mature T cells, NK-T cells
Function: TCR signal transduction, T cell activation, antigen recognition
Ligand/Receptor: Peptide antigen/MHC-complex
Cell Type: NKT cells, T cells, Thymocytes, Tregs
Biology Area: Immunology
Molecular Family: CD Molecules, TCRs
Antigen References: 1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Davis MM. 1990. Annu. Rev. Biochem. 59:475. 3. Weiss A, et al. 1994. Cell 76:263.
Gene ID: 12501
UniProt: View information about CD3epsilon on UniProt.org
Clone: 145-2C11
Regulatory Status: RUO
Other Names: CD3ε, T3, CD3
Isotype: Armenian Hamster IgG